Analyst Price Targets — DRMA
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 21, 2024 7:49 am | Anthony Vendetti | Maxim Group | $6.00 | $2.07 | StreetInsider | Dermata Therapeutics In (DRMA) PT Lowered to $6 at Maxim Group |
Latest News for DRMA
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026
- Dermata announced their Tome Skincare brand for direct-to-consumer ("DTC") skincare products - - Dermata plans to launch its first DTC product, the Tome Foundational Treatment, a once-weekly mask to support skin renewal, in the middle of 2026 - - Raised $2.0 million in net proceeds from it's at-the-market ("ATM") financing facility - SAN DIEGO, CA / ACCESS Newswire / May 13, 2026 / Dermata Therapeutics, Inc.…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for DRMA.
U.S. House Trading
No House trades found for DRMA.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.